Precision Medicine News and Updates | Precision Medicine Online
WEBThe plan, announced in January, would reclassify many Class III in vitro diagnostic devices as Class II, impacting companion diagnostic and infectious disease tests. Precision Medicine Online provides the latest news for healthcare leaders and scientists interested in precision medicine and individualized approaches to treatment and prevention.
Precision Oncology News - Precision Medicine Online
WEBSep 16, 2024. AI-Driven Genomic Test Shows Promise in De-Escalating Neoadjuvant TNBC Therapy. Sep 15, 2024. TORL BioTherapeutics' CLDN6-Targeting Antibody-Drug Conjugate Demonstrates Encouraging Early Results. Sep 15, 2024. Bristol Myers Squibb's Krazati Bests Chemo in KRAS-Mutant NSCLC With Brain Metastases. Sep 15, 2024.
Disease Research & Diagnostics News | Precision Medicine Online
WEBNews and analysis on disease research and diagnostics from Precision Medicine Online.
Precision Medicine Diagnostics
WEBBioNexus Gene Lab, Shenzhen Rongguang Team up on Cancer Screening, Precision Medicine Programs. Sep 13, 2024. AbbVie's Telisotuzumab Vedotin Effective in NSCLC Patients With High, Intermediate c-MET Expression. Sep 12, 2024. Cancer Centers Look to New NGS-Based 'Frankenpanel' to Get Fast Info on Clinically Actionable Genes.
Breaking News - Precision Medicine Online
WEBSep 13, 2024 · IN8bio to Lay off Nearly Half of Workforce, Narrow Pipeline Focus on AML Cell Therapy. The firm is dropping two glioblastoma programs and cutting 49 percent of its staff to advance its gamma delta T-cell therapy INB …
Autoimmune Disease Research News - Precision Medicine Online
WEBJun 20, 2024 · JW Therapeutics, 2seventy Bio Partner to Develop Cell Therapy for Autoimmune Diseases in China. News on research and diagnostics in autoimmune disorders including rheumatoid arthritis, lupus, multiple sclerosis, and more from Precision Medicine Online.
Precision Oncology in 2022: New Drugs and Tests Amid Ongoing …
WEBJan 4, 2023 · NEW YORK – Looking back at 2022, plenty of new CAR T-cell, radioligand, and biomarker-defined treatments entered the market, as did new tissue and liquid biopsy tests to identify cancer patients eligible for these therapies.
Breaking News - Precision Medicine Online
WEBUnder the agreement, the companies aim to discover new drug targets in cardiovascular and renal diseases using Quotient's cell phenotyping and genomic sequencing platform.
Medical Imaging News - Precision Medicine Online
WEBThe TumorSight Viz application aims to make breast cancer treatment planning more precise through 3D tumor images built from standard-of-care medical imaging.
Cardiovascular Disease Research News - Precision Medicine Online
WEBJul 3, 2024 · News on molecular diagnostics, pharmacogenomics tests for coronary artery disease, congenital heart defects, and more from Precision Medicine Online.